Twist Bioscience vs Figma

Side-by-side comparison of AI visibility scores, market position, and capabilities

Figma leads in AI visibility (99 vs 16)
Twist Bioscience logo

Twist Bioscience

GrowthLife Sciences & BioTech

Synthetic Biology & DNA Synthesis

Synthetic DNA manufacturing platform on silicon chips; $376M FY2025 revenue (+20% YoY). Supplies synthetic genes to 3,000+ customers across biotech, pharma, and AgBio.

AI VisibilityBeta
Overall Score
D16
Category Rank
#1 of 1
AI Consensus
68%
Trend
up
Per Platform
ChatGPT
20
Perplexity
10
Gemini
23

About

Twist Bioscience was founded in 2013 in San Francisco by Emily Leproust, Bill Banyai, and Bill Peck, pioneering a silicon-based DNA synthesis platform that writes synthetic DNA at a fraction of the cost and error rate of conventional methods. By printing DNA on silicon wafers using a semiconductor-like process, Twist dramatically reduced the cost of synthetic genes from hundreds to single-digit dollars per gene, democratizing access to DNA writing for the life sciences.\n\nTwist serves over 3,000 customers across biopharmaceuticals, academic research, agriculture, and industrial biotechnology, offering synthetic genes, variant libraries, DNA data storage oligos, and antibody libraries for drug discovery. The company reported $376.6 million in FY2025 revenue, up 20% from $313 million in FY2024, driven by strong growth in its biopharma and drug discovery segments. Twist also operates a growing antibody drug discovery business, providing synthetic antibody libraries that power next-generation therapeutic discovery programs.\n\nTwist has a supply agreement with Ginkgo Bioworks for synthetic DNA to fuel Ginkgo's cell engineering platform, revised in 2025. The company is executing toward profitability, with improving gross margins as manufacturing scale increases. Its silicon-based DNA synthesis platform positions it as critical infrastructure for the emerging bioeconomy, synthetic biology, and DNA data storage industries.

Full profile
Figma logo

Figma

LeaderDesign & Creative Tools

Design & Collaboration

Dominant browser-based collaborative UI design platform at ~$600M ARR and $12.5B valuation; Adobe's $20B acquisition blocked by regulators in 2023, Figma remains independent competing with Sketch and Adobe.

AI VisibilityBeta
Overall Score
A99
Category Rank
#1 of 1
AI Consensus
77%
Trend
stable
Per Platform
ChatGPT
90
Perplexity
99
Gemini
97

About

Figma is a San Francisco-based collaborative web-based product design platform that has become the dominant tool for UI/UX designers and product teams — enabling real-time multi-user collaboration on interface design, prototyping, and design system management directly in the browser without installing desktop software. Founded in 2012 by Dylan Field and Evan Wallace and backed by Sequoia, Greylock, and Andreessen Horowitz with over $330 million raised, Figma generated approximately $600 million in ARR in 2023, serving 4 million+ designers and product teams at companies including Microsoft, Airbnb, Twitter, and Uber. Adobe announced a $20 billion acquisition offer in 2022, which was blocked by regulators in 2023 — Figma remains independent.

Full profile

AI Visibility Head-to-Head

16
Overall Score
99
#1
Category Rank
#1
68
AI Consensus
77
up
Trend
stable
20
ChatGPT
90
10
Perplexity
99
23
Gemini
97
17
Claude
94
13
Grok
99

Capabilities & Ecosystem

Capabilities

Only Twist Bioscience
Synthetic Biology & DNA Synthesis
Only Figma
Design & Collaboration

Integrations

Figma is classified as company.

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.